Series B Investors & VC Firms in Europe

1431 firms in this list, with a median first check of $648K. 338 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
DE Debiopharm Innovation Fund MCTMCTDS18 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Late Stage	$1M – $5M	+ Add to CRM
NE Nextech Invest ASJLWG3 people	88🔒	Zurich	CH	Seed–Late Stage	$648K – $3.2M	+ Add to CRM
EX Expeditions MFSKEMSB8 people · Leads rounds	88🔒	Warsaw	PL	Seed–Series B	—	+ Add to CRM
ST Starquest Capital ADEGHDOK14 people	88🔒	Paris	FR	Seed–Growth	$530K – $21.2M	+ Add to CRM
AC Act Venture Capital JFMRSCDR10 people	88🔒	Dublin	IE	Seed–Late Stage	—	+ Add to CRM
TH The Craftory ELESAMAD16 people · Leads rounds	88🔒	London	GB	Seed–Late Stage	$15M – $150M	+ Add to CRM
BL BlackPeak Capital IGRIASAS18 people · Leads rounds	88🔒	Sofia	BG	Series B–Growth	—	+ Add to CRM
PY Pymwymic RPAKMVMM19 people	88🔒	Amsterdam	NL	Seed–Late Stage	$5.4M	+ Add to CRM
13 13books Capital MMSGATBW12 people · Leads rounds	88🔒	London	GB	Seed–Series C	$1.3M – $8.9M	+ Add to CRM
T. T.Capital TLMSOSTS24 people	88🔒	Hamburg	DE	Seed–Late Stage	—	+ Add to CRM
BL Blossom Capital IGMFKKMB11 people · Follows rounds	88🔒	London	GB	Seed–Series B	—	+ Add to CRM
AN Anterra Capital AAMGBWMH17 people · Follows rounds	88🔒	Amsterdam	NL	Seed–Late Stage	$20M	+ Add to CRM
FO Forestay Capital FWDPKWJR14 people · Leads rounds	88🔒	London	GB	Series A–Growth	$10M – $20M	+ Add to CRM
IW IW Capital TAAAAPCL17 people	88🔒	London	GB	Seed–Growth	—	+ Add to CRM
FI Finberg AGGOKÖMA6 people · Follows rounds	88🔒	Istanbul	TR	Seed–Late Stage	$244K – $20M	+ Add to CRM
SC Sciety ALMLFSMN21 people · Leads rounds	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
UC UCL Technology Fund AEAECRDG14 people	88🔒	London	GB	Pre-Seed–Growth	$320K – $9M	+ Add to CRM
CE CEI Africa CJAVAHBS25 people	88🔒	Amsterdam	NL	Pre-Seed–Growth	—	+ Add to CRM
DR Droia Ventures GGJNLBLD13 people · Follows rounds	88🔒	Leuven	BE	Pre-Seed–Series B	$540K	+ Add to CRM
LI Limburgse Reconversie Maatschappij DBDEKWDR22 people	88🔒	Hasselt	BE	Seed–Late Stage	$27K – $10.8M	+ Add to CRM
CR CREAS IMPACTO GLOBAL SGEIC LBPJLVOM21 people	88🔒	Madrid	ES	Seed–Growth	—	+ Add to CRM
KF KfW Capital	88🔒	Frankfurt am Main	DE	Pre-Seed–Growth	—	+ Add to CRM
TE TempoCap GCASCGMK12 people	88🔒	London	GB	Series B–Series C	—	+ Add to CRM
ZE Zero Gravity Capital MZAĎDDMJ14 people · Leads rounds	88🔒	Bratislava	SK	Pre-Seed–Series B	$210K	+ Add to CRM

Debiopharm Innovation Fund

LausannePre-Seed–Late Stage$1M – $5M

MCTMCTDS18 people

Nextech Invest

ZurichSeed–Late Stage$648K – $3.2M

ASJLWG3 people

Expeditions

WarsawSeed–Series B

MFSKEMSB8 people

Starquest Capital

ParisSeed–Growth$530K – $21.2M

ADEGHDOK14 people

Act Venture Capital

DublinSeed–Late Stage

JFMRSCDR10 people

The Craftory

LondonSeed–Late Stage$15M – $150M

ELESAMAD16 people

BlackPeak Capital

SofiaSeries B–Growth

IGRIASAS18 people

Pymwymic

AmsterdamSeed–Late Stage$5.4M

RPAKMVMM19 people

13books Capital

LondonSeed–Series C$1.3M – $8.9M

MMSGATBW12 people

T.Capital

HamburgSeed–Late Stage

TLMSOSTS24 people

Blossom Capital

LondonSeed–Series B

IGMFKKMB11 people

Anterra Capital

AmsterdamSeed–Late Stage$20M

AAMGBWMH17 people

Forestay Capital

LondonSeries A–Growth$10M – $20M

FWDPKWJR14 people

IW Capital

LondonSeed–Growth

TAAAAPCL17 people

Finberg

IstanbulSeed–Late Stage$244K – $20M

AGGOKÖMA6 people

Sciety

StockholmSeed–Growth

ALMLFSMN21 people

UCL Technology Fund

LondonPre-Seed–Growth$320K – $9M

AEAECRDG14 people

CEI Africa

AmsterdamPre-Seed–Growth

CJAVAHBS25 people

Droia Ventures

LeuvenPre-Seed–Series B$540K

GGJNLBLD13 people

Limburgse Reconversie Maatschappij

HasseltSeed–Late Stage$27K – $10.8M

DBDEKWDR22 people

CREAS IMPACTO GLOBAL SGEIC

MadridSeed–Growth

LBPJLVOM21 people

KfW Capital

Frankfurt am MainPre-Seed–Growth

TempoCap

LondonSeries B–Series C

GCASCGMK12 people

Zero Gravity Capital

BratislavaPre-Seed–Series B$210K

MZAĎDDMJ14 people

Data sourced from public filings and firms' own websites — see our methodology.